https://scholars.lib.ntu.edu.tw/handle/123456789/522343
標題: | Treatment with the herbal formulation Eefooton slows the progression of chronic kidney disease: A case report | 作者: | CHIEN-AN YAO Lin C.-H. |
關鍵字: | chronic kidney disease; end-stage renal disease; hemodialysis; herbal formula; peritoneal dialysis | 公開日期: | 2019 | 出版社: | Lippincott Williams and Wilkins | 卷: | 98 | 期: | 43 | 來源出版物: | Medicine (United States) | 摘要: | Rationale:Patients with end-stage kidney disease (ESKD) receiving maintenance dialysis experience an overall burden of physical and emotional symptoms. However, there were limited alternative treatments to dialysis.Patient concerns:A 79-year-old woman with chronic kidney disease stage 5 (CKD5) and gout had refused to be on dialysis. She also had hypoglycemia, hypertension, and heart disease.Diagnoses:The patient had received the ultrasonography, the renal biopsy and biochemical examinations, confirming the diagnosis of renal impairment, primary hypertension, and chronic nephritic syndrome with unspecified morphologic changes.Interventions:She was administered with 20 mL Eefooton (a liquid formula of herbal extracts: Astragalus membranaceus 3 g, Codonopsis pilosula 3 g, Ligustrum lucidum 3 g, Panax quinquefolius 1.3 g, and Rhodiola sacra 1.3 g) orally twice a day for 6 months in addition to her regular medications.Outcomes:The patient was followed up for 3 months after the completion of the Eefooton adjuvant treatment. The patient's renal function was improved, and CKD progression was alleviated. After Eefooton treatment, the sizes of both kidneys in the patient increased by 8% while blood urea nitrogen (BUN) and serum creatinine concentrations were decreased. In addition, further reduction in BUN concentration was observed 2 months posttreatment.Lessons:This case demonstrated that Eefooton has potential therapeutic significance in patients with CKD5 who chose conservative treatment over dialysis. Copyright ? 2019 the Author(s). Published by Wolters Kluwer Health, Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074083960&doi=10.1097%2fMD.0000000000017573&partnerID=40&md5=a3e4307c9607be031363390c7ad20946 https://scholars.lib.ntu.edu.tw/handle/123456789/522343 |
ISSN: | 0025-7974 | DOI: | 10.1097/MD.0000000000017573 | SDG/關鍵字: | ascorbic acid; bicarbonate; bisbentiamine; calcium; calcium carbonate; carbon dioxide; carvedilol; colchicine; creatinine; eefooton; esomeprazole; febuxostat; ferrous gluconate; folic acid; hemoglobin; herbaceous agent; lansoprazole; losartan potassium; nitrogen; paracetamol plus tramadol; phosphate; potassium; recombinant erythropoietin; sennoside A; sennoside B; thiamine; unclassified drug; urea; plant extract; aged; Article; Astragalus membranaceus; blood biochemistry; calcium blood level; carbon dioxide blood level; case report; chronic kidney failure; clinical article; Codonopsis pilosula; creatinine blood level; echography; evening dosage; female; gout; heart disease; hematocrit; herbal medicine; human; hypertension; hypoglycemia; kidney biopsy; Ligustrum lucidum; morning dosage; nephritis; Panax quinquefolius; phosphate blood level; potassium blood level; priority journal; urea nitrogen blood level; chronic kidney failure; complication; conservative treatment; disease exacerbation; phytotherapy; procedures; treatment outcome; Aged; Conservative Treatment; Disease Progression; Female; Humans; Phytotherapy; Plant Extracts; Renal Insufficiency, Chronic; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。